1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics in the United States, November 2019

Healthcare Analysis & Statistics in the United States, November 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

  • All
    • Pharma Intelligence

All regions

data types

1-30 of about 300 reports

Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
tislelizumab

tislelizumab

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTislelizumab (BeiGene) is a humanized monoclonal antibody that was designed to bind to the PD-1 receptor and prevent binding of PD-L1. In addition, tislelizumab was designed to minimize binding ...

  • Industries : Pathology, Medical Biotechnology
  • Countries : United States
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Menveo

Menveo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenveo (quadrivalent oligosaccharide diphtheria CRM-197 conjugate vaccine; GlaxoSmithKline) is a quadrivalent meningococcal glycoconjugate vaccine that uses CRM-197, a natural mutant of the ...

  • Industries : Therapy, Pathology
  • Countries : United States, European Union
Menactra

Menactra

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenactra (Sanofi) is a quadrivalent polysaccharide diphtheria toxoid conjugate vaccine indicated for active immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria ...

  • Industries : Therapy, Pathology
  • Countries : United States
Trumenba

Trumenba

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTrumenba (Pfizer) is a bivalent recombinant meningococcal serogroup B vaccine indicated for immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup ...

  • Industries : Pathology
  • Countries : United States
Bexsero

Bexsero

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewBexsero (multicomponent meningococcal serogroup B vaccine; GlaxoSmithKline) is a multicomponent meningococcal serogroup B vaccine. It is approved for the prevention of invasive meningococcal ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States, European Union
MenABCW-135Y

MenABCW-135Y

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewGlaxoSmithKline’s MenABCW-135Y is a pentavalent meningococcal conjugate vaccine for the A, B, C, W-135, and Y meningococcal strains. With all of the vaccine’s announced Phase II trials ...

  • Industries : Pathology, Therapy
  • Countries : United States, European Union
Drug Delivery: Inhalation Devices

Drug Delivery: Inhalation Devices

  • $ 4750
  • Industry report
  • October 2019

OverviewIn 2018, combined sales of inhaled asthma and COPD devices in the countries covered by this analysis totaled approximately $10.4bn. Over the forecast period covered by this analysis, total sales ...

  • Industries : Drug Delivery, Chronic Disease, Pathology
  • Countries : United States, Japan
Global Market for Fracture Fixation Devices

Global Market for Fracture Fixation Devices

  • $ 4750
  • Industry report
  • August 2019

OverviewThis medical market and technology report provides a comprehensive discussion of the global market for fracture fixation devices. Geographic markets covered by this analysis include the US, Japan, ...

  • Industries : Health Services
  • Countries : United States, World, Japan
Market Spotlight: Gout, Pharma Intelligence

Market Spotlight: Gout, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

This Market Spotlight report covers the Gout market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World
Market Spotlight: Glaucoma, Pharma Intelligence

Market Spotlight: Glaucoma, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

OverviewThis Market Spotlight report covers the Glaucoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, probability of success, patent information, ...

  • Industries : Health Services, Pathology
  • Countries : United States, World
Market Spotlight: Endometriosis, Pharma Intelligence

Market Spotlight: Endometriosis, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

This Market Spotlight report covers the Endometriosis market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • Industries : Pathology
  • Countries : United States, World
Market Spotlight: Myelofibrosis, Pharma Intelligence

Market Spotlight: Myelofibrosis, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

Myelofibrosis is a myeloproliferative neoplasm which can exist as a primary disease known as primary myelofibrosis, or can evolve to post- polycythemia vera (PV) or post-essential thrombocythemia (ET) ...

  • Industries : Pathology
  • Countries : United States
Market Spotlight: Hodgkin’s Lymphoma, Pharma Intelligence

Market Spotlight: Hodgkin’s Lymphoma, Pharma Intelligence

  • $ 1318
  • Industry report
  • October 2019

This Market Spotlight report covers the Hodgkin’s Lymphoma market, comprising key marketed and pipeline drugs, clinical trials, key upcoming and regulatory events, recent events and analyst opinion, ...

  • Industries : Cancer, Pathology
  • Countries : World, United States
Market Spotlight: Glioblastoma

Market Spotlight: Glioblastoma

  • $ 1318
  • Industry report
  • September 2019

This Market Spotlight report covers the Glioblastoma market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • Industries : Cancer, Pathology
  • Countries : United States, World
Market Spotlight: Norovirus, Pharma Intelligence

Market Spotlight: Norovirus, Pharma Intelligence

  • $ 1318
  • Industry report
  • September 2019

This Market Spotlight report covers the Norovirus market, comprising key pipeline drugs, clinical trials, probability of success, key upcoming events, and an epidemiological overview.Key TakeawaysWorldwide, ...

  • Industries : Pathology
  • Countries : United States, World
Market Spotlight: Fibromyalgia

Market Spotlight: Fibromyalgia

  • $ 1318
  • Industry report
  • September 2019

This Market Spotlight report covers the Fibromyalgia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of success, patent ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, United States
Market Spotlight: Acne, Pharma Intelligence

Market Spotlight: Acne, Pharma Intelligence

  • $ 1318
  • Industry report
  • September 2019

This Market Spotlight report covers the Acne market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, ...

  • Industries : Pathology
  • Countries : United States, World
Market Spotlight: Celiac Disease, Pharma Intelligence

Market Spotlight: Celiac Disease, Pharma Intelligence

  • $ 1318
  • Industry report
  • August 2019

This Market Spotlight report covers the Celiac Disease market, comprising key pipeline drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, and licensing ...

  • Industries : Pathology
  • Countries : United States, World
Triple-Negative Breast Cancer KOL Interview – US

Triple-Negative Breast Cancer KOL Interview – US

  • $ 599
  • Industry report
  • October 2019

A US-based key opinion leader providers insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for triple- negative breast cancer. Diagnostic testing, biomarker disease ...

  • Industries : Therapy, Oncology
  • Countries : United States
Rheumatoid Arthritis Payer Interview – Pennsylvania, US

Rheumatoid Arthritis Payer Interview – Pennsylvania, US

  • $ 599
  • Industry report
  • August 2019

OverviewA US payer provides insights into pricing and reimbursement dynamics and issues surrounding biosimilars, key marketed brands, and late-phase pipeline therapies for rheumatoid arthritis.

  • Industries : Medical Biotechnology, Chronic Disease, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Rheumatoid Arthritis KOL Interview – California, US

Rheumatoid Arthritis KOL Interview – California, US

  • $ 599
  • Industry report
  • July 2019

A US-based key opinion leader provides insights into prescribing habits, the most pressing unmet needs in the market, the role of biosimilars, key marketed brands, and late-phase pipeline therapies fo ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on